This study may help identify how abnormalities in brain systems that control the ability to
ignore irrelevant information may contribute to the development of depression in older
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01728194
Ages eligible for Study
60 Years to 85 Years
Genders eligible for Study
Accepts Healthy Volunteers
Age: 60-85 years, right-handed;
Diagnosis: Major depression, unipolar (by Structured Clinical Interview for Diagnostic and Statistical Manual (DSM)IV (SCID-R) and DSM-IV criteria);
Age of onset of first episode ≥ 50 years with up to three depressive episodes;
Severity of depression: A 24-Item Hamilton Depression Rating Scale (HDRS) ≥ 20.
Psychotic depression by DSM-IV, i.e., presence of delusions with a SCID-R score higher than 2;
High suicide risk, i.e. intent or plan to attempt suicide in near future;
Presence of any Axis I psychiatric disorder (other than unipolar major depression) or substance abuse;
History of psychiatric disorders other than unipolar major depression or generalized anxiety disorder (bipolar disorder, hypomania, and dysthymia are exclusion criteria);
Dementia: Diagnosis of dementia by DSM-IV;
Mild Cognitive Impairment (MCI);
Acute or severe medical illness, i.e., delirium, metastatic cancer, decompensated cardiac, liver or kidney failure, major surgery, stroke or myocardial infarction during the three months prior to entry; or use of drugs known to cause depression, e.g., reserpine, alpha-methyl-dopa, steroids, sympathomimetics withdrawal;
Neurological brain disease and/or history of electroconvulsive therapy;
History of any use of citalopram or escitalopram during the current episode or need for drugs that may interact with these agents, i.e. drug metabolized by the 2D6 P450 isoenzyme system;
Current involvement in psychotherapy;
Contraindications to MRI scanning including cardiac pacemaker, metallic objects and metallic implants contraindicating MRI, cardiac stent, claustrophobia;
Inability to speak English;
Corrected visual acuity < 20/70; Color blindness.
All locations for NCT01728194
United States (2)
Weill Cornell Medical College
New York, New York, United States, 10065
Weill Cornell Medical College - Westchester Division
White Plains, New York, United States, 10605
View full eligibility
Tris trial is registered with FDA with number: NCT01728194. The sponsor of the trial is Weill Medical College of Cornell University and it is looking for 121 volunteers for the current phase.
Official trial title: White Matter and Emotional and Cognitive Control in Late-Onset Depression
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Thank you for applying!
We'll contact you soon with more information.
Consult your doctor?
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.